The global bone growth stimulator market is projected to experience steady growth over the next decade, driven by advances in orthopedic technologies, increasing prevalence of bone fractures, and growing patient preference for non-invasive therapies. Valued at USD 1,131.25 million in 2024 , the market is expected to grow to USD 1,855.88 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2025 to 2034. Bone growth stimulators (BGS) are medical devices used to enhance bone healing following fractures, surgeries, or trauma. The market’s growth is propelled by technological advancements in bone regeneration therapies , rising rates of osteoporosis, and an aging population, all of which are driving demand for orthopedic devices that can improve healing outcomes and accelerate recovery. Market Overview Bone growth stimulators are used to stimulate bone healing by applying electric or electromagnetic fields to the frac...